Benitec Biopharma Inc.

NasdaqCM:BNTC Stok Raporu

Piyasa değeri: US$228.7m

Benitec Biopharma Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Jerel Banks

İcra Kurulu Başkanı

US$2.8m

Toplam tazminat

CEO maaş yüzdesi22.4%
CEO görev süresi6.4yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi6.4yrs
Yönetim Kurulu ortalama görev süresi9.1yrs

Son yönetim güncellemeleri

Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Nov 30
Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Recent updates

Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth

Oct 02
Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth

Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Nov 30
Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Benitec Biopharma prices of $18M securities offering

Sep 13

Benitec GAAP EPS of -$2.23, revenue of $0.07M

Sep 02

We're A Little Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate

Jan 13
We're A Little Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate

We Think Benitec Biopharma (NASDAQ:BNTC) Needs To Drive Business Growth Carefully

Sep 30
We Think Benitec Biopharma (NASDAQ:BNTC) Needs To Drive Business Growth Carefully

Will Benitec Biopharma (NASDAQ:BNTC) Spend Its Cash Wisely?

May 12
Will Benitec Biopharma (NASDAQ:BNTC) Spend Its Cash Wisely?

Benitec Bio secures $13M capital via equity offering

Apr 28

Can Benitec Biopharma (NASDAQ:BNTC) Afford To Invest In Growth?

Jan 27
Can Benitec Biopharma (NASDAQ:BNTC) Afford To Invest In Growth?

How Does Benitec Biopharma's (NASDAQ:BNTC) CEO Salary Compare to Peers?

Dec 02
How Does Benitec Biopharma's (NASDAQ:BNTC) CEO Salary Compare to Peers?

CEO Tazminat Analizi

Jerel Banks'un ücretlendirmesi Benitec Biopharma'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$21m

Jun 30 2024US$3mUS$628k

-US$22m

Mar 31 2024n/an/a

-US$22m

Dec 31 2023n/an/a

-US$22m

Sep 30 2023n/an/a

-US$21m

Jun 30 2023US$919kUS$540k

-US$20m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022n/an/a

-US$19m

Sep 30 2022n/an/a

-US$18m

Jun 30 2022US$800kUS$506k

-US$18m

Mar 31 2022n/an/a

-US$17m

Dec 31 2021n/an/a

-US$18m

Sep 30 2021n/an/a

-US$16m

Jun 30 2021US$1mUS$440k

-US$14m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020n/an/a

-US$11m

Sep 30 2020n/an/a

-US$10m

Jun 30 2020US$632kUS$400k

-US$8m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019n/an/a

-US$6m

Sep 30 2019n/an/a

-US$2m

Jun 30 2019US$615kUS$400k

US$3m

Mar 31 2019n/an/a

US$2m

Dec 31 2018n/an/a

US$2m

Sep 30 2018n/an/a

-US$3m

Jun 30 2018US$91kn/a

-US$9m

Tazminat ve Piyasa: Jerel 'nin toplam tazminatı ($USD 2.80M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.44M ).

Tazminat ve Kazançlar: Jerel şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Jerel Banks (49 yo)

6.4yrs

Görev süresi

US$2,798,977

Tazminat

Dr. Jerel A. Banks, Ph D., M.D., has been the Chief Executive Officer of Benitec Biopharma Inc. since June 26, 2018. Dr. Banks has been the Executive Chairman of the Board at Benitec Biopharma Inc. since O...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jerel Banks
Executive Chairman & CEO6.4yrsUS$2.80mVeri yok
Megan Boston
Executive Director6.4yrsUS$1.28m0.11%
$ 255.4k
Michael Graham
Head of Discovery & Founding Scientist9.4yrsUS$238.78kVeri yok
Claudia Kloth
Senior Vice President of Manufacturingno dataVeri yokVeri yok

6.4yrs

Ortalama Görev Süresi

Deneyimli Yönetim: BNTC 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.4 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jerel Banks
Executive Chairman & CEO8.1yrsUS$2.80mVeri yok
Megan Boston
Executive Director8.3yrsUS$1.28m0.11%
$ 255.4k
J. Buchi
Independent Non-Executive Director11.6yrsUS$159.97k0.22%
$ 513.2k
Peter Francis
Independent Non-Executive Director18.8yrsUS$154.51k0.000080%
$ 182.9
Edward Smith
Independent Non-Executive Director4.6yrsUS$152.47k0%
$ 0
Kishan Mehta
Directorless than a yearVeri yokVeri yok
Geoffrey McCaughan
Member of Hepatology Clinical Advisory Board9.1yrsVeri yokVeri yok
Harry Janssen
Member of Hepatology Clinical Advisory Board9.1yrsVeri yokVeri yok
Keyur Patel
Member of Hepatology Clinical Advisory Board9.1yrsVeri yokVeri yok
George Dickson
Member of Scientific & Clinical Advisory Boardno dataVeri yokVeri yok

9.1yrs

Ortalama Görev Süresi

52.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BNTC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.1 yıldır).